Abstract
Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.
Philip J Mease, Dennis A Revicki, Jacek Szechinski, Maria Greenwald, Alan Kivitz, Leonor Barile-Fabris, Jatinderpal Kalsi, Jennifer Eames and Marjatta Leirisalo-Repo
The Journal of Rheumatology January 2008, 35 (1) 20-30;
Philip J Mease
Dennis A Revicki
Jacek Szechinski
Maria Greenwald
Alan Kivitz
Leonor Barile-Fabris
Jatinderpal Kalsi
Jennifer Eames
Marjatta Leirisalo-Repo
In this issue
Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.
Philip J Mease, Dennis A Revicki, Jacek Szechinski, Maria Greenwald, Alan Kivitz, Leonor Barile-Fabris, Jatinderpal Kalsi, Jennifer Eames, Marjatta Leirisalo-Repo
The Journal of Rheumatology Jan 2008, 35 (1) 20-30;
Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.
Philip J Mease, Dennis A Revicki, Jacek Szechinski, Maria Greenwald, Alan Kivitz, Leonor Barile-Fabris, Jatinderpal Kalsi, Jennifer Eames, Marjatta Leirisalo-Repo
The Journal of Rheumatology Jan 2008, 35 (1) 20-30;